Please use this identifier to cite or link to this item: https://doi.org/10.1021/ic301884j
Title: Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B
Authors: Ong, J.X.
Yap, C.W. 
Ang, W.H. 
Issue Date: 19-Nov-2012
Source: Ong, J.X., Yap, C.W., Ang, W.H. (2012-11-19). Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B. Inorganic Chemistry 51 (22) : 12483-12492. ScholarBank@NUS Repository. https://doi.org/10.1021/ic301884j
Abstract: Protein tyrosine phosphatases (PTPs) belong to a large family of important regulatory enzymes involved in vital mammalian signaling pathways. Selective inhibitors of PTPs are highly valuable from a therapeutic standpoint given their association with various pathological conditions. One such target is PTP-1B which has previously been linked to diabetes and cancer. However, developing a selective inhibitor against PTP-1B has proven to be daunting because the enzyme shares a high degree of structural homology with TC-PTP, an essential PTP involved in modulating immune functions. To address this challenge, a series of organoruthenium complexes was developed to bind at the PTP substrate-binding site while simultaneously target the peripheral structural space. By capitalizing on the potential difference in the structural environment proximal to the active site between different PTPs, selectivity toward PTP-1B over TC-PTP was improved, paving the way for organoruthenium complexes as selective PTP-1B metalloinhibitors. © 2012 American Chemical Society.
Source Title: Inorganic Chemistry
URI: http://scholarbank.nus.edu.sg/handle/10635/53128
ISSN: 00201669
DOI: 10.1021/ic301884j
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

31
checked on Mar 7, 2018

WEB OF SCIENCETM
Citations

27
checked on Mar 7, 2018

Page view(s)

47
checked on Apr 21, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.